A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

被引：0
|
作者：
Sharma, SK
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 04期
关键词：
D O I：
10.1016/j.amjcard.2003.07.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：524 / 525
页数：2
相关论文
共 50 条
  • [1] A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention
    Vakili, BA
    Kaplan, RC
    Slater, JN
    Sherman, W
    Ravi, KL
    Green, SJ
    Sanborn, T
    Brown, DL
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08): : 946 - 950
  • [2] Glycoprotein IIb/IIIa inhibitor therapy and outcomes after percutaneous coronary intervention
    Tepper, RI
    Simonian, N
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06): : 771 - 772
  • [3] Impact of Platelet Glycoprotein IIb/IIIa Inhibitor Therapy on In-Hospital Outcomes and Long-Term Survival Following Percutaneous Coronary Rotational Atherectomy
    Jeffrey S. Berger
    James N. Slater
    Warren Sherman
    Stephen J. Green
    Timothy A. Sanborn
    David L. Brown
    Journal of Thrombosis and Thrombolysis, 2005, 19 : 47 - 54
  • [4] Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy
    Berger, JS
    Slater, JN
    Sherman, W
    Green, SJ
    Sanborn, TA
    Brown, DL
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 19 (01) : 47 - 54
  • [5] Improved in-hospital outcomes after percutaneous coronary intervention in the era of routine Glycoprotein IIb/IIIa inhibition and stenting
    Jackevicius, CA
    Mackie, K
    Seidelin, P
    Minor, S
    Daly, P
    Barolet, A
    Schwartz, L
    McLaughlin, P
    Ing, D
    Ross, J
    Dzavik, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 440A - 440A
  • [6] New platelet glycoprotein IIb/IIIa inhibitor trials in percutaneous coronary intervention
    Topol, EJ
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 : 3C - 6C
  • [7] Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy
    Galli, M
    CIRCULATION, 2001, 104 (25) : E163 - E163
  • [8] In-hospital outcome is improved in women after percutaneous coronary intervention and is similar to that in men in the era of routine platelet glycoprotein IIb/IIIa inhibition and stenting
    Dzavik, V
    Jackevicius, C
    Ross, J
    Schwartz, L
    Mackie, K
    McLaughlin, P
    Barolet, A
    Daly, P
    Ing, D
    Miner, S
    Seidelin, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 455A - 455A
  • [9] IMMEDIATE AND REVERSIBLE PLATELET INHIBITION AFTER INTRAVENOUS ADMINISTRATION OF A PEPTIDE GLYCOPROTEIN IIB/IIIA INHIBITOR DURING PERCUTANEOUS CORONARY INTERVENTION
    HARRINGTON, RA
    KLEIMAN, NS
    KOTTKEMARCHANT, K
    LINCOFF, AM
    TCHENG, JE
    SIGMON, KN
    JOSEPH, D
    RIOS, G
    TRAINOR, K
    ROSE, D
    GREENBERG, CS
    KITT, MM
    TOPOL, EJ
    CALIFF, RM
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17): : 1222 - 1227
  • [10] The impact of glycoprotein IIb/IIIa inhibitors on in-hospital outcomes in octogenarians after elective percutaneous coronary intervention: A report from the New York State Angioplasty registry.
    Sharma, A
    Minutello, RM
    Chou, ET
    Yang, F
    Kong, JA
    Kim, SS
    Parikh, MA
    Bergman, G
    Hong, MK
    Wong, SC
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 114E - 114E
12345